Coronation Africa raises stake in Macro Pharmaceutical to 5.11%

Getty Images

Founded in 2002, Macro Group is a leading Egyptian cosmeceutical company based in Cairo

Staff Writer, Arab Finance

March 9, 2023

PHOTO

Coronation Africa Frontiers Fund Universal (CORAFFA) raised its stake in Macro Group Pharmaceutical (Macro Capital) (MCRO) from 4.89% to 5.11%, according to a statement filed to the Egyptian Exchange (EGX) on March 8th.

The fund bought 1.3 million shares of Macro Pharmaceutical at a total value of EGP 4.222 million or an average purchase price of EGP 3.23 per share.

Macro Pharmaceutical posted a 17.51% year-on-year (YoY) increase in its consolidated net profits after tax and non-controlling interests during the full year ended December 31st 2022.

Founded in 2002, Macro Group is a leading Egyptian cosmeceutical company based in Cairo.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.